These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28089966)

  • 21. Contamination Control.
    Akers MJ
    Int J Pharm Compd; 2015; 19(3):232-8. PubMed ID: 26714364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monitoring minimization of grade B environments based on risk assessment using three-dimensional airflow measurements and computer simulation.
    Katayama H; Higo T; Tokunaga Y; Katoh S; Hiyama Y; Morikawa K
    PDA J Pharm Sci Technol; 2008; 62(4):244-55. PubMed ID: 19174953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Equipment and analytical companies meeting continuous challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
    Page T; Dubina H; Fillipi G; Guidat R; Patnaik S; Poechlauer P; Shering P; Guinn M; Mcdonnell P; Johnston C
    J Pharm Sci; 2015 Mar; 104(3):821-31. PubMed ID: 25448273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Active air vs. passive air (settle plate) monitoring in routine environmental monitoring programs.
    Andon BM
    PDA J Pharm Sci Technol; 2006; 60(6):350-5. PubMed ID: 17260900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk analysis of sterile production plants: a new and simple, workable approach.
    Gapp G; Holzknecht P
    PDA J Pharm Sci Technol; 2011; 65(3):217-26. PubMed ID: 22293233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of Milliflex
    Gordon O; Goverde M; Staerk A; Roesti D
    PDA J Pharm Sci Technol; 2017; 71(3):206-224. PubMed ID: 28196917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Different Calculation Approaches for Defining Microbiological Control Levels Based on Historical Data.
    Gordon O; Goverde M; Pazdan J; Staerk A; Roesti D
    PDA J Pharm Sci Technol; 2015; 69(3):383-98. PubMed ID: 26048745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Continuous microbiological air monitoring for aseptic filling lines.
    Ginsbury K
    PDA J Pharm Sci Technol; 2007; 61(4):225. PubMed ID: 17933205
    [No Abstract]   [Full Text] [Related]  

  • 29. Use of a real-time microbial air sampler for operational cleanroom monitoring.
    Eaton T; Wardle C; Whyte W
    PDA J Pharm Sci Technol; 2014; 68(2):172-84. PubMed ID: 24668604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of quality risk management to set viable environmental monitoring frequencies in biotechnology processing and support areas.
    Sandle T
    PDA J Pharm Sci Technol; 2012; 66(6):560-79. PubMed ID: 23183652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Throughput Optimization of Continuous Biopharmaceutical Manufacturing Facilities.
    Garcia FA; Vandiver MW
    PDA J Pharm Sci Technol; 2017; 71(3):189-205. PubMed ID: 27974629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation and characterization of the environmental bacterial and fungi contamination in a pharmaceutical unit of mesenchymal stem cell for clinical use.
    Martín PG; González MB; Martínez AR; Lara VG; Naveros BC
    Biologicals; 2012 Sep; 40(5):330-7. PubMed ID: 22795333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cleaning verification: A five parameter study of a Total Organic Carbon method development and validation for the cleaning assessment of residual detergents in manufacturing equipment.
    Li X; Ahmad IAH; Tam J; Wang Y; Dao G; Blasko A
    J Pharm Biomed Anal; 2018 Feb; 149():33-39. PubMed ID: 29100028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proposal for a new categorization of aseptic processing facilities based on risk assessment scores.
    Katayama H; Toda A; Tokunaga Y; Katoh S
    PDA J Pharm Sci Technol; 2008; 62(4):235-43. PubMed ID: 19174952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Method Verification Requirements for an Advanced Imaging System for Microbial Plate Count Enumeration.
    Jones D; Cundell T
    PDA J Pharm Sci Technol; 2018; 72(2):199-212. PubMed ID: 29242391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation study on how to avoid microbial contamination during pharmaceutical production.
    Shintani H
    Biocontrol Sci; 2015; 20(1):1-10. PubMed ID: 25817807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulatory and quality considerations for continuous manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Allison G; Cain YT; Cooney C; Garcia T; Bizjak TG; Holte O; Jagota N; Komas B; Korakianiti E; Kourti D; Madurawe R; Morefield E; Montgomery F; Nasr M; Randolph W; Robert JL; Rudd D; Zezza D
    J Pharm Sci; 2015 Mar; 104(3):803-12. PubMed ID: 25830179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Some observations on airborne particles in the critical areas of a blow-fill-seal machine.
    Sundström S; Ljungqvist B; Reinmüller B
    PDA J Pharm Sci Technol; 2009; 63(1):71-80. PubMed ID: 19455943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disinfectant Efficacy: Understanding the Expectations and How to Design Effective Studies That Include Leveraging Multi-Site Data to Drive an Efficient Program.
    Willison-Parry D; Yang S; Forng RY; Cirbo T; Mcmeel A; Kiler B; Phillion C
    PDA J Pharm Sci Technol; 2020; 74(2):249-263. PubMed ID: 31732692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of Methods for Recovering Endotoxins from Surfaces and from Air in Production Environment of Injectable Drugs.
    Fiammetta F; Carducci A; Davini G; Macchia M; Bertini S; Vecchiani S; Ceccanti S
    PDA J Pharm Sci Technol; 2017; 71(6):502-510. PubMed ID: 28819048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.